Related Experiment Video
Updated: Aug 18, 2026

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing
Published on: June 9, 2017
Differential expression and stability of endogenous nuclear factor E2-related factor 2 (Nrf2) by natural
Woo-Sik Jeong1, Young-Sam Keum, Chi Chen
1Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers-The State University of New Jersey, Piscataway, NJ 08854, USA.
Abstract:
Nuclear factor-E2-related factor 2 (Nrf2) is known as a key regulator of ARE-mediated gene expression and the induction of Phase II detoxifying enzymes and antioxidant enzymes, which is also a common property of many chemopreventive agents. In the present study, we investigated the regulatory role of different chemopreventive agents including sulforaphane (SUL), allyl isothiocyanate (AITC), indole-3-carbinol (I3C), and parthenolide (PTL), in the expression and degradation of Nrf2 and the induction of the antioxidant enzyme HO-1. SUL strongly induced Nrf2 protein expression and ARE-mediated transcription activation, retarded degradation of Nrf2 through inhibiting Keap1, and thereby activating the transcriptional expression of HO-1. AITC was also a potent inducer of Nrf2 protein expression, ARE-reporter gene and HO-1 but had little effect on delaying the degradation of Nrf2 protein. Although PTL and I3C could induce AREreporter gene expression and Nrf2 to some extent, they were not as potent as SUL and AITC. However, PTL dramatically induced the HO-1 expression, which was comparable to SUL, while I3C had no effect. In addition, when treated with SUL and PTL, inhibition of proteasome by MG132 did not cause additional accumulation of Nrf2, suggesting the involvement of other degradation mechanism(s) in the presence of these compounds such as SUL and PTL. In summary, the results of our current study indicated that different chemopreventive compounds have different regulatory properties on the accumulation and degradation of Nrf2 as well as the induction of cellular antioxidant enzyme HO-1.
Insights
Different chemopreventive agents regulate Nuclear factor-E2-related factor 2 (Nrf2) differently. Some agents inhibit Nrf2 degradation, enhancing antioxidant enzyme HO-1 expression, while others impact Nrf2 accumulation through distinct mechanisms.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Nuclear factor-E2-related factor 2 (Nrf2) is a master regulator of antioxidant and detoxification genes.
- Chemopreventive agents often modulate Nrf2 activity.
- Understanding Nrf2 regulation by these agents is crucial for developing cancer prevention strategies.
Purpose of the Study:
- To investigate how different chemopreventive agents (sulforaphane, allyl isothiocyanate, indole-3-carbinol, parthenolide) affect Nrf2 expression, degradation, and HO-1 induction.
- To compare the regulatory mechanisms of these agents on the Nrf2 pathway.
Main Methods:
- Treatment of cells with sulforaphane (SUL), allyl isothiocyanate (AITC), indole-3-carbinol (I3C), and parthenolide (PTL).
- Assessment of Nrf2 protein levels, ARE-mediated transcription, and HO-1 expression.
- Investigation of Nrf2 degradation pathways, including proteasome inhibition (MG132).
Main Results:
- Sulforaphane strongly induced Nrf2 and HO-1 by inhibiting Keap1-mediated degradation.
- Allyl isothiocyanate induced Nrf2 and HO-1 but had minimal impact on Nrf2 degradation.
- Parthenolide significantly induced HO-1, with Nrf2 regulation not solely dependent on proteasomal degradation.
Conclusions:
- Chemopreventive agents exhibit diverse regulatory effects on Nrf2 accumulation and degradation.
- These distinct mechanisms influence the induction of antioxidant enzymes like HO-1.
- Findings highlight the complex interplay between chemopreventives and the Nrf2 pathway.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Cell Specific Gene Expression
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...